Stocks
REGENXBIO (RGNX) EBITDA margin US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -62.6% | 36.0% | -228.0% | -216.7% | -265.4% | -266.9% | |
| Changes by years, y/y, % | +194pp | +99pp | -264pp | +11pp | -49pp | |||
REGENXBIO. EBITDA margin, %
REGENXBIO. EBITDA margin, changes, pp
REGENXBIO (RGNX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -193.2% | -258.2% | -366.0% | -217.5% | -256.6% | -266.9% | |
| Changes by years, y/y, % | +61pp | -74pp | -21pp | +126pp | -63pp | |||
| Changes by quarters, q/q, % | +150pp | -65pp | -108pp | +149pp | -39pp | |||
